Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of new ...
5don MSN
Truveta launches AI research tool to get quick insights from big database of U.S. clinical data
Bellevue, Wash.-based health data company Truveta announced Truveta Intelligence, a new AI-powered tool that lets researchers ...
The platform is co-led by Dr. Sherry Soltani, Chief Medical Officer, who brings an active clinical perspective to seeCOLe’s ...
As the use of digital tools continues to expand within clinical research, effective data management for eCOA systems is more important than ever. From initial design and system setup to ongoing ...
PHILADELPHIA, April 28, 2026--iECURE to Present Preliminary Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal ...
An FDA initiative to implement real-world clinical trials could dramatically accelerate the pace at which new treatments ...
A surge of AI and data science tools is set to transform clinical trial design, patient recruitment, and drug development efficiency, according to industry leaders ahead of the Biomed Israel ...
This article is part of our series on clinical data considerations. Read How to Prepare for Disclosure. For publicly traded biotech companies, disclosing clinical trial data can be an exciting ...
A detailed look at the benchmarking methodology used to measure clinical accuracy in the OpenVet AI hospital. MIAMI, ...
TOS-358 is a covalent, pan-mutant, α-specific PI3K inhibitor designed to address key limitations of existing PI3Kα therapies which include limited mutation coverage and poor tolerability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results